Vertex begins telaprevir rolling NDA

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) began submission of a rolling NDA to FDA for telaprevir to treat HCV. The company plans to complete the submission for the small molecule HCV NS3/4A protease ...